Linked Life Data

17490879

Source:http://linkedlifedata.com/resource/pubmed/id/17490879

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17490879rdf:typepubmed:Citationlld:pubmed
pubmed-article:17490879lifeskim:mentionsumls-concept:C0034242lld:lifeskim
pubmed-article:17490879lifeskim:mentionsumls-concept:C0201734lld:lifeskim
pubmed-article:17490879lifeskim:mentionsumls-concept:C1260969lld:lifeskim
pubmed-article:17490879lifeskim:mentionsumls-concept:C0243077lld:lifeskim
pubmed-article:17490879lifeskim:mentionsumls-concept:C1706204lld:lifeskim
pubmed-article:17490879lifeskim:mentionsumls-concept:C1555721lld:lifeskim
pubmed-article:17490879lifeskim:mentionsumls-concept:C0439611lld:lifeskim
pubmed-article:17490879lifeskim:mentionsumls-concept:C0231449lld:lifeskim
pubmed-article:17490879lifeskim:mentionsumls-concept:C0216510lld:lifeskim
pubmed-article:17490879pubmed:issue13lld:pubmed
pubmed-article:17490879pubmed:dateCreated2007-6-18lld:pubmed
pubmed-article:17490879pubmed:abstractTextA study on substitutions at the four open positions on the phenyl ring of the 1,4-dihydroindeno[1,2-c]pyrazoles as potent CHK-1 inhibitors is described. Bis-substitution at both the 6- and 7-positions led to inhibitors with IC(50) values below 0.3nM. The compound with the best overall activities (36) was able to potentiate the anti-proliferative effect of doxorubicin in HeLa cells by at least 47-fold. Physicochemical, metabolic, and pharmacokinetic properties of selected inhibitors are also disclosed.lld:pubmed
pubmed-article:17490879pubmed:languageenglld:pubmed
pubmed-article:17490879pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17490879pubmed:citationSubsetIMlld:pubmed
pubmed-article:17490879pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17490879pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17490879pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17490879pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17490879pubmed:statusMEDLINElld:pubmed
pubmed-article:17490879pubmed:monthJullld:pubmed
pubmed-article:17490879pubmed:issn0960-894Xlld:pubmed
pubmed-article:17490879pubmed:authorpubmed-author:WuJianJlld:pubmed
pubmed-article:17490879pubmed:authorpubmed-author:ClaiborneAkiy...lld:pubmed
pubmed-article:17490879pubmed:authorpubmed-author:KovarPeterPlld:pubmed
pubmed-article:17490879pubmed:authorpubmed-author:ShamHing LHLlld:pubmed
pubmed-article:17490879pubmed:authorpubmed-author:TaoZhi-FuZFlld:pubmed
pubmed-article:17490879pubmed:authorpubmed-author:RosenbergSaul...lld:pubmed
pubmed-article:17490879pubmed:authorpubmed-author:StewartKent...lld:pubmed
pubmed-article:17490879pubmed:authorpubmed-author:SowinThomas...lld:pubmed
pubmed-article:17490879pubmed:authorpubmed-author:ZhangHaiyingHlld:pubmed
pubmed-article:17490879pubmed:authorpubmed-author:ChenZehanZlld:pubmed
pubmed-article:17490879pubmed:authorpubmed-author:TongYunsongYlld:pubmed
pubmed-article:17490879pubmed:authorpubmed-author:BouskaJennife...lld:pubmed
pubmed-article:17490879pubmed:authorpubmed-author:GuanRanRlld:pubmed
pubmed-article:17490879pubmed:authorpubmed-author:MertaPhilip...lld:pubmed
pubmed-article:17490879pubmed:authorpubmed-author:EverittElizab...lld:pubmed
pubmed-article:17490879pubmed:authorpubmed-author:HickmanDeanDlld:pubmed
pubmed-article:17490879pubmed:authorpubmed-author:CredoRobert...lld:pubmed
pubmed-article:17490879pubmed:authorpubmed-author:PyzytulinskaM...lld:pubmed
pubmed-article:17490879pubmed:authorpubmed-author:MurryBernard...lld:pubmed
pubmed-article:17490879pubmed:authorpubmed-author:StrattonTim...lld:pubmed
pubmed-article:17490879pubmed:authorpubmed-author:LinNan-horngN...lld:pubmed
pubmed-article:17490879pubmed:issnTypePrintlld:pubmed
pubmed-article:17490879pubmed:day1lld:pubmed
pubmed-article:17490879pubmed:volume17lld:pubmed
pubmed-article:17490879pubmed:ownerNLMlld:pubmed
pubmed-article:17490879pubmed:authorsCompleteYlld:pubmed
pubmed-article:17490879pubmed:pagination3618-23lld:pubmed
pubmed-article:17490879pubmed:dateRevised2011-11-2lld:pubmed
pubmed-article:17490879pubmed:meshHeadingpubmed-meshheading:17490879...lld:pubmed
pubmed-article:17490879pubmed:meshHeadingpubmed-meshheading:17490879...lld:pubmed
pubmed-article:17490879pubmed:meshHeadingpubmed-meshheading:17490879...lld:pubmed
pubmed-article:17490879pubmed:meshHeadingpubmed-meshheading:17490879...lld:pubmed
pubmed-article:17490879pubmed:meshHeadingpubmed-meshheading:17490879...lld:pubmed
pubmed-article:17490879pubmed:meshHeadingpubmed-meshheading:17490879...lld:pubmed
pubmed-article:17490879pubmed:meshHeadingpubmed-meshheading:17490879...lld:pubmed
pubmed-article:17490879pubmed:meshHeadingpubmed-meshheading:17490879...lld:pubmed
pubmed-article:17490879pubmed:meshHeadingpubmed-meshheading:17490879...lld:pubmed
pubmed-article:17490879pubmed:meshHeadingpubmed-meshheading:17490879...lld:pubmed
pubmed-article:17490879pubmed:meshHeadingpubmed-meshheading:17490879...lld:pubmed
pubmed-article:17490879pubmed:meshHeadingpubmed-meshheading:17490879...lld:pubmed
pubmed-article:17490879pubmed:meshHeadingpubmed-meshheading:17490879...lld:pubmed
pubmed-article:17490879pubmed:meshHeadingpubmed-meshheading:17490879...lld:pubmed
pubmed-article:17490879pubmed:meshHeadingpubmed-meshheading:17490879...lld:pubmed
pubmed-article:17490879pubmed:year2007lld:pubmed
pubmed-article:17490879pubmed:articleTitle1,4-Dihydroindeno[1,2-c]pyrazoles as potent checkpoint kinase 1 inhibitors: extended exploration on phenyl ring substitutions and preliminary ADME/PK studies.lld:pubmed
pubmed-article:17490879pubmed:affiliationCancer Research, Global Pharmaceutical R&D, R47S, AP10, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, IL 60064, USA. yunsong.tong@abbott.com <yunsong.tong@abbott.com>lld:pubmed
pubmed-article:17490879pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:17490879lld:chembl